Effect of serum FGF-23, MGP and fetuin-A on calcium-phosphate metabolism in maintenance hemodialysis patients

Hemodialysis International

Volumn 17, Issue 4, 2013, Pages 483-492

  Xiao, Dong Mei ^a,c   Wu, Qing ^a   Fan, Wei Feng ^a   Ye, Xian Wu ^a   Niu, Jian Ying ^a   Gu, Yong ^a,b  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c NINGBO UNIVERSITY   (China)

Author keywords

Calcium and phosphate metabolism; Coronary artery calcification score; Fetuin A; Fibroblast growth factor 23; Maintenance hemodialysis; Matrix Gla protein

Indexed keywords

CALCIUM; FETUIN A; FIBROBLAST GROWTH FACTOR 23; HIGH DENSITY LIPOPROTEIN; MATRIX GLA PROTEIN; OSTEOCALCIN; PHOSPHATE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CALCIUM METABOLISM; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY CALCIUM SCORE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PHOSPHATE METABOLISM; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; YOUDEN INDEX;

CALCIUM AND PHOSPHATE METABOLISM; CORONARY ARTERY CALCIFICATION SCORE; FETUIN-A; FIBROBLAST GROWTH FACTOR 23; MAINTENANCE HEMODIALYSIS; MATRIX GLA PROTEIN;

ADULT; AGED; AGED, 80 AND OVER; ALPHA-2-HS-GLYCOPROTEIN; CALCIUM; CALCIUM-BINDING PROTEINS; EXTRACELLULAR MATRIX PROTEINS; FEMALE; FIBROBLAST GROWTH FACTORS; HUMANS; MALE; MIDDLE AGED; PHOSPHATES; RENAL DIALYSIS;

EID: 84884989050     PISSN: 14927535     EISSN: 15424758     Source Type: Journal    
DOI: 10.1111/hdi.12033     Document Type: Article

References (46)

1. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl. 2009; 113:S1-130.
2. Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol. 2004; 15:2208-2218.
3. London GM, Guerin AP, Marchais SJ, Métivier F, Pannier B, Adda H. Aterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant. 2003; 18:1731-1740.
4. Gal-Moscovici A, Sprague SM. Role of vitamin D deficiency in chronic kidney disease. J Bone Miner Res. 2007; 22:V91-V94.
5. Goodman WG, Goldin J, Kuizon BD, etal. Coronary artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med. 2000; 342:1478-1483.
6. Kondos GT, Hoff JA, Sevrukov A, etal. Electron-beam tomography coronary artery calcium and cardiac events: a 37-month follow-up of 5635 initially asymptomatic low- to intermediate-risk adults. Circulation. 2003; 107:2571-2576.
7. Matsuoka M, Iseki K, Tamashiro M, etal. Impact of high coronary artery calcification score (CACS) on survival in patients on chronic hemodialysis. Clin Exp Nephrol. 2004; 8:54-58.
8. Fensterseifer DM, Karohl C, Schvartzman P, Costa CAR, Veronese FJV. Coronary calcification and its association with mortality in haemodialysis patients. Nephrology (Carlton). 2009; 14:164-170.
9. Cannata-Andia JB, Rodriguez-Garcia M, Carrillo-Lopez N, Naves-Diaz M, Diaz-Lopez B. Vascular calcifications: pathogenesis, management, and impact on clinical outcomes. J Am Soc Nephrol. 2006; 17:S267-S273.
10. Moe SM, Chen NX. Pathophysiology of vascular calcification in chronic kidney disease. Circ Res. 2004; 95:560-567.
11. Parker BD, Schurgers LJ, Brandenburg VM, etal. The associations of fibroblast growth factor 23 and uncarboxylated matrix gla protein with mortality in coronary artery disease: the Heart and Soul Study. Ann Intern Med. 2010; 152:640-648.
12. Guerin AP, London GM, Marchais SJ, Metivier F. Arterial stiffening and vascular calcifications in end-stage renal disease. Nephrol Dial Transplant. 2000; 15:1014-1021.
13. Moe SM, Reslerova M, Ketteler M, etal. Role of calcification inhibitors in the pathogenesis of vascular calcification in chronic kidney disease(CKD). Kidney Int. 2005; 67:2295-2304.
14. Cozzolino M, Galassi A, Biondi ML, etal. Serum fetuin-A levels link inflammation and cardiovascular calcification in hemodialysis patients. Am J Nephrol. 2006; 26:423-429.
15. Bláha V, Mistrík E, Dusilová-Sulková S, etal. Circulating fetuin-A predicts early mortality in chronic hemodialysis patients. Clin Biochem. 2009; 42:996-1000.
16. Caliskan Y, Demirturk M, Ozkok A, etal. Coronary artery calcification and coronary flow velocity in haemodialysis patients. Nephrol Dial Transplant. 2010; 25:2685-2690.
17. Hermans MM, Brandenburg V, Ketteler M, etal. Study on the relationship of serum fetuin-A concentration with aortic stiffness in patients on dialysis. Nephrol Dial Transplant. 2006; 21:1293-1299.
18. Mikami S, Hamano T, Fujii N, etal. Serum osteoprotegerin as a screening tool for coronary artery calcification score in diabetic pre-dialysis patients. Hypertens Res. 2008; 31:1163-1170.
19. Ix JH, Katz R, de Boer IH, etal. Fetuin-A is inversely associated with coronary artery calcification in community-living persons: the multi-ethnic study of atherosclerosis. Clin Chem. 2012; 58:887-895.
20. Tintut Y, Patel J, Parhami F, Demer LL. Tumor necrosis factor-α promotes in vitro calcification of vascular cells via the cAMP pathway. Circulation. 2000; 102:2636-2642.
21. Chertow GM, Burke SK, Raggi P. Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int. 2002; 62:245-252.
22. Kanatani M, Sugimoto T, Kano J, Chihara K. IGF-I mediates the stimulatory effect of high phosphate concentration on osteoblastic cell proliferation. J Cell Physiol. 2002; 190:306-312.
23. Brandenburg VM, Schlieper G, Heussen N, etal. Serological cardiovascular and mortality risk predictors in dialysis patients receiving sevelamer: a prospective study. Nephrol Dial Transplant. 2010; 25:2672-2679.
24. Raggi P, Boulay A, Chasan-Taber S, etal. Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease. J Am Coll Cardiol. 2002; 39:695-701.
25. McCullough PA, Sandberg KR, Dumler F, Yanez JE. Determinants of coronary vascular calcification in patients with chronic kidney disease and end-stage renal disease: a systematic review. J Nephrol. 2004; 17:205-215.
26. Guo YS, Yuan WJ, Mei XB, etal. Coronary artery calcification leads to cardiac functional and structural changes and its correlative factors in maintenance hemodialysis patients. Chin J Nephrol. 2007; 23:167-171.
27. Bian WJ, Zhang L, Chen YP, Lv B. Coronary artery calcification measured with electron beam computed tomography and its correlative factors in hemodialysis patients. Chin J Nephrol. 2005; 21:65-68.
28. Choi YH, Hong YJ, Park IH, etal. Relationship between coronary artery calcium score by multidetector computed tomography and plaque components by virtual histology intravascular ultrasound. J Korean Med Sci. 2011; 26:1052-1060.
29. Kaysen GA. Lipid and lipoprotein metabolism in chronic kidney disease. J Ren Nutr. 2009; 19:73-77.
30. Koch M, Kutkuhn B, Grabensee B, Ritz E. Apolipoprotein A, fibrinogen, age, and history of stroke are predictors of death in dialysed diabetic patients: a prospective study in 412 subjects. Nephrol Dial Transplant. 1997; 12:2603-2611.
31. Liao CT, Kao TW, Chou YH, etal. Associations of metabolic syndrome and its components with cardiovascular outcomes among non-diabetic patients undergoing maintenance peritoneal dialysis. Nephrol Dial Transplant. 2011; 26:4047-4054.
32. Parhami F, Basseri B, Hwang J, Tintut Y, Demer LL. High-density lipoprotein regulates calcification of vascular cells. Circ Res. 2002; 91:570-576.
33. Pruijm M, Schmidtko J, Aho A, etal. High prevalence of anti-apolipoprotein/A-1 autoantibodies in maintenance hemodialysis and associationwith dialysis vintage. Ther Apher Dial. 2012; 16:588-594.
34. Stenvinkel P, Carrero JJ, Axelsson J, Lindholm B, Heimburger O, Massy Z. Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle? Clin J Am Soc Nephrol. 2008; 3:505-521.
35. Packard RR, Libby P. Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction. Clin Chem. 2008; 54:24-38.
36. Stoll G, Bendszus M. Inflammation and atherosclerosis: novel insights into plaque formation and destabilization. Stroke. 2006; 37:1923-1932.
37. Van Lenten BJ, Hama SY, de Beer FC, etal. Antiinflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures. J Clin Invest. 1995; 96:2758-2767.
38. Cengiz N, Baskin E, Sezgin N, Agras P, Haberal M. Oxidative stress in children on hemodialysis: value of autoantibodies against oxidized low-density lipoprotein. Pediatr Nephrol. 2009; 24:387-393.
39. Maggi E, Bellazzi R, Gazo A, Seccia M, Bellomo G. Autoantibodies against oxidatively-modified LDL in uremic patients undergoing dialysis. Kidney Int. 1994; 46:869-876.
40. Mirams M, Robinson BG, Mason RS, Nelson AE. Bone as a source of FGF23: regulation by phosphate. Bone. 2004; 35:1192-1119.
41. Kolek OI, Hines ER, Jones MD, etal. 1 alpha, 25-dihydroxy vitamin D3 up-regulates FGF23 gene expression in bone: the final link in a renal-gastrointestinal-skeletal axis that controls phosphate transport. Am J Physiol Gastrointest Liver Physiol. 2005; 289:1036-1042.
42. Desjardins L, Liabeuf S, Renard C, etal. FGF23 is independently associated with vascular calcification but not bone mineral density in patients at various CKD stages. Osteoporos Int. 2012; 23:2017-2025.
43. Roos M, Lutz J, Salmhofei H, etal. Relation between plasma fibroblast growth factor-23, serum fetuin-A levels and coronary artery calcification evaluated by multislice computed tomography in patients with normal kidney function. Clin Endocrinol (Oxf). 2008; 68:660-665.
44. Schurgers LJ, Barreto DV, Barreto FC, etal. The circulating inactive form of matrix gla protein is a surrogate marker for vascular calcification in chronic kidney disease: a preliminary report. Clin J Am Soc Nephrol. 2010; 5:568-575.
45. Shea MK, O'Donnell CJ, Vermeer C, etal. Circulating uncarboxylated matrix gla protein is associated with vitamin K nutritional status, but not coronary artery calcium, in older adults. J Nutr. 2011; 141:1529-1534.
46. Westenfeld R, Schafer C, Smeets R, etal. Fetuin-A (AHSG) prevents extraosseous calci fication induced by uraemia and phosphate challenge in mice. Nephrol Dial Transplant. 2007; 22:1537-1546.